findmyKOL
Clinical trialNCT05299697UnknownPhase 2Interventional

A Study of TG103 Injection in Overweight or Obesity

SponsorCSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Enrollment195Overweight or Obesity
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Baotou City Central Hospital

    Baotou, Neimenggu, China

    Tao Ning
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 May 2022
Primary completion
30 Jun 2023
Completion
30 Sept 2023
Last update posted
23 May 2022
Registered enrollment
195
Registry id
NCT05299697

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.